Skip to content
AwardedSpainGoods

Medicamentos biológicos con biosimilares (AM INGESA 2021/064)

Published
Published 20 February 2025

Overview

Medicamentos biológicos con biosimilares (AM INGESA 2021/064)

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Selective
Published
20 February 2025
Classification (CPV)
Antineoplastic and immunomodulating agentsImmunosuppressive agents

Award outcome

Awarded value
€274,217
Award date
14 February 2025
Winners
  • AMGEN,S.A.
  • KERN PHARMA, S.L.
  • PFIZER S.L.U.
  • SANDOZ FARMACEUTICA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 February 2025

Contracting authority

  • Servicio Cántabro de Salud

    Procuring entity

    Santander, Spain

    ID_PLATAFORMA: 21012270144987

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Medicamentos biológicos con biosimilares (AM INGESA 2021/064) — won by AMGEN,S.A. +3 — Skim